Search

everythinglearnresearchcommunity

for

Search:↓

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Axitinib treatment turned a man's grey hair back to black.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Blocking IL-8 can reduce skin rashes from cancer treatment.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Increasing XIAP and DDRGK1 can help prevent hearing loss from loud noise.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Panax ginseng extract may help prevent hair loss caused by DKK-1.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.